Show simple item record

dc.contributor.authorColomba, E
dc.contributor.authorLe Teuff, G
dc.contributor.authorEisen, T
dc.contributor.authorStewart, GD
dc.contributor.authorFife, K
dc.contributor.authorLarkin, J
dc.contributor.authorBiondo, A
dc.contributor.authorPickering, L
dc.contributor.authorSrinivasan, A
dc.contributor.authorBoyle, H
dc.contributor.authorDerosa, L
dc.contributor.authorSternberg, CN
dc.contributor.authorRecine, F
dc.contributor.authorRalph, C
dc.contributor.authorSaldana, C
dc.contributor.authorBarthelemy, P
dc.contributor.authorBernhard, JC
dc.contributor.authorGurney, H
dc.contributor.authorVerhoest, G
dc.contributor.authorVauleon, E
dc.contributor.authorBigot, P
dc.contributor.authorBerger, J
dc.contributor.authorPfister, C
dc.contributor.authorGravis, G
dc.contributor.authorRodier, J-M
dc.contributor.authorCuline, S
dc.contributor.authorCaty, A
dc.contributor.authorRolland, F
dc.contributor.authorPriou, F
dc.contributor.authorEscudier, B
dc.contributor.authorAlbiges, L
dc.date.accessioned2018-02-20T12:00:24Z
dc.date.issued2017-07
dc.identifierhttp://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000403329300008&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=d4b848928d1c3e5c86d298abb68475f9
dc.identifier.citationEUROPEAN JOURNAL OF CANCER, 2017, 80 pp. 55 - 62
dc.identifier.issn0959-8049
dc.identifier.urihttps://repository.icr.ac.uk/handle/internal/1398
dc.identifier.eissn1879-0852
dc.identifier.doi10.1016/j.ejca.2017.03.011
dc.format.extent55 - 62
dc.languageeng
dc.language.isoeng
dc.subjectNon-clear cell RCC
dc.subjectChromophobe RCC
dc.subjectMetastatic
dc.subjectAnti-angiogenic
dc.subjectVEGF
dc.subjectmTOR
dc.titleMetastatic chromophobe renal cell carcinoma treated with targeted therapies: A Renal Cross Channel Group study
dc.typeJournal Article
rioxxterms.versionofrecord10.1016/j.ejca.2017.03.011
rioxxterms.licenseref.startdate2017-07
rioxxterms.typeJournal Article/Review
dc.relation.isPartOfEUROPEAN JOURNAL OF CANCER
pubs.notesNot known
pubs.organisational-group/ICR
pubs.organisational-group/ICR/Primary Group
pubs.organisational-group/ICR/Primary Group/ICR Divisions
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Clinical Studies
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Clinical Studies/Melanoma and Kidney Cancer
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Clinical Studies/Melanoma and Kidney Cancer/Melanoma and Kidney Cancer (hon.)
pubs.organisational-group/ICR/Primary Group/Royal Marsden Clinical Units
pubs.organisational-group/ICR
pubs.organisational-group/ICR/Primary Group
pubs.organisational-group/ICR/Primary Group/ICR Divisions
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Clinical Studies
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Clinical Studies/Melanoma and Kidney Cancer
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Clinical Studies/Melanoma and Kidney Cancer/Melanoma and Kidney Cancer (hon.)
pubs.organisational-group/ICR/Primary Group/Royal Marsden Clinical Units
pubs.publication-statusPublished
pubs.volume80
pubs.embargo.termsNot known
icr.researchteamMelanoma and Kidney Canceren_US
dc.contributor.icrauthorLarkin, Jamesen
dc.contributor.icrauthorMarsden,en


Files in this item

Thumbnail

This item appears in the following collection(s)

Show simple item record